Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome
Recruiting now
Conditions studied: Heart Failure, Kidney Diseases, Kidney Injury, Heart Valve Diseases, Dialysis; Complications, Coronary Heart Disease
In brief
To estimate the characteristics, pathogenesis, risk factors and intervention measures for different stages of heart and kidney diseases, and to optimize the curative effects of different treatment schemes
Key facts
- Study ID
- NCT05397392
- Run by
- Nanjing First Hospital, Nanjing Medical University
- People needed
- 1200
- Starts
- 2016-01-01
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2022-06-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients meet the diagnosis of various types of cardiorenal syndrome according to the classification standards of various types formulated by KDIGO and ADQI expert consensus. Different syndromes were identified and classified into five subtypes. Acute CRS (type 1): acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. Chronic cardio-renal syndrome (type 2): chronic abnormalities in heart function (CHF-CHD) leading to kidney injury and/or dysfunction. Acute reno-cardiac syndrome (type 3): acute worsening of kidney function (AKI) leading to heart injury and/or dysfunction. Chronic reno-cardiac syndrome (type 4): chronic kidney disease leading to heart injury, disease, and/or dysfunction. Secondary CRS (type 5): systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney.
You may not qualify if…
- Pregnant or breastfeeding women; Female patients with recent birth plans; Patients who cannot follow up on medications.
Where it is running
- Study site — Nanjing, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.